SBMP - disrupting the manufacturing of biological drugs through a ground-breakin...
SBMP - disrupting the manufacturing of biological drugs through a ground-breaking nanotechnology-based microcarrier
Cellevate proposes a completely novel type of nanofibrous microcarriers for adherent cell culture in bioreactors based on the proprietary Superior Biologics Manufacturing Platform (SBMP). It is a game-changing deep-tech innovation...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
RYC-2013-14905
Biofunctionalization of micro and nanostructured materials f...
309K€
Cerrado
CTQ2015-64538-R
NANOQUIMICA CON BACTERIAS, BIOPOLIMEROS Y BIOFIBRAS
85K€
Cerrado
RYC-2013-12640
Micro and nano-fabrication, biomaterials, biosensors, microf...
309K€
Cerrado
FIDB13-4E-2094
FORTALECIMIENTO Y CONSOLIDACIÓN DE LA PLATAFORMA DE NANOTECN...
551K€
Cerrado
JCI-2011-10737
Novel biomaterials and advanced drug carrier systems includi...
96K€
Cerrado
TEC2017-85059-C3-2-R
(BIO)FUNCIONALIZACION DE SUSPENSIONES DE MICRO-Y NANOHERRAMI...
121K€
Cerrado
Información proyecto SBMP-microcarrier
Duración del proyecto: 22 meses
Fecha Inicio: 2022-11-11
Fecha Fin: 2024-09-30
Líder del proyecto
CELLEVATE AB
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Cellevate proposes a completely novel type of nanofibrous microcarriers for adherent cell culture in bioreactors based on the proprietary Superior Biologics Manufacturing Platform (SBMP). It is a game-changing deep-tech innovation for the biopharmaceutical industry. SBPM-microcarriers
are highly customizable, faithfully replicate the 3D extracellular environment found in the human body, and provide a 60 times larger area for cell growth compared to competitive solutions. The unique scaffold properties are a result of a patent-pending nanofiber scaffold production
technology (PCT/EP2020/081958) which creates networks of polymer nanofibers that can be handled in a liquid form, unachievable by competing solutions. By offering high yields and ensuring the optimal conditions for human cell growth, SBMP-microcarriers have the potential to transform the
biopharmaceutical market by pushing the limits of today’s biological drugs production to an unachievable level of quality and efficiency.